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Impact of Pre-Operative
Malperfusion on
Acute Type A Dissection
The Modiﬁed Penn ClassiﬁcationWe read with great interest the recent article re-
ported by Czerny et al. (1) who performed an
analysis of a large database to address an importantissue showing that malperfusion remained a severe
clinical condition with strong potential for adverse
outcomes in patients of acute type A aortic
dissection (ATAAD) undergoing surgery while the
impact differed substantially in accordance with the
number and the type of organ malperfusion
involved. Therefore, they proposed a classiﬁcation
system of “complicated” and “uncomplicated”
ATAAD to help predict risk of outcomes. We want
to congratulate the investigators for shedding light
on the important issue of the impact of malperfu-
sion on operative mortality risk for patients with
ATAAD. The investigators provided valuable scien-
tiﬁc evidences which conﬁrmed and extended the
viewpoint of ischemic consequences of organ mal-
perfusion and end-organ dysfunction that compro-
mised survival (2,3), although some investigators
still argued that generalized ischemia in ATAAD
predicted early surgical outcomes only (4). The
issue of generalized ischemia caused by circulatory
collapse, distinct from localized organ ischemia, is a
very well taken point to be emphasized as the most
important predictor of outcome after surgical repair
of ATAAD and associated with the highest in-
hospital mortality regardless of treatment strategy
(3–5). In 2009, Augoustides et al. (2) reported an
observational study of mortality risk stratiﬁcation
by ischemic presentation in patients with ATAAD,
so-called Penn classiﬁcation, which has been vali-
dated by subsequent investigators (see references 1
and 5 in Chien et al. [5]) and has shown merit to be
a useful risk assessment system in predicting
ATAAD-related in-hospital mortality (4,5). Never-
theless, Penn classiﬁcation might still underesti-
mate the surgical risk of ATAAD in the setting with
critical organ-speciﬁc ischemia (including mesen-
teric ischemia, sustained major cerebral ischemia,
and coronary malperfusion). From this point of
view, we have proposed to modify the original
Penn classiﬁcation and suggested to divide the
Penn class Ab into subclasses Ab-1 and Ab-2
(Table 1) (5). Based on this consideration, we
studied the relationship of ischemic presentations
to 30-day mortality after surgical repair in 179 pa-
tients from 1997 to 2014 (mean age, 59  12 years;
124 men; classes Aa [n ¼ 60], Ab-1 [n ¼ 44], Ab-2
[n ¼ 27], Ac [n ¼ 10], and Abc [n ¼ 38]). It was
found that subclass Ab-2 had much higher mortality
rate than that of subclass Ab-1 (22.2% vs. 2.3%),
however, without statistical signiﬁcance (p ¼ 0.175).
One possible explanation is the small number of
our patients suffered from localized malperfusion
(Ab-1 or Ab-2). Nevertheless, we do think that
subclass Ab-2 remains a surgical challenge and is
TABLE 1 Modiﬁed Penn Classiﬁcation of Ischemic Presentations in Patients With
Acute Type A Aortic Dissection
Class Deﬁnition
Penn Class Aa Absence of branch vessel malperfusion or circulatory collapse
Penn Class Ab Branch vessel malperfusion with localized malperfusion
Subclass Ab-1 Localized malperfusion without involving critical organs of subclass Ab-2
Subclass Ab-2 Major cerebral, mesenteric, and coronary malperfusion
Penn Class Ac Generalized malperfusion because of circulatory collapse
Penn Class Abc Both localized and generalized malperfusion
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cal repair (3) (see references 2, 8, and 12 in Chien
et al. [5]). Of note, class Aa þ Ab-1 (odds ratio [OR]:
0.17, 95% conﬁdence interval [CI]: 0.064 to 0.444;
p < 0.001) and class Ab-2 þ Ac þ Abc (OR: 5.94,
95% CI: 2.251 to 15.671; p < 0.001) were respectively
relieving and exacerbating independent factors for
30-day mortality (5.8% vs. 26.7%, p < 0.001). Thus,
it seems that a mixed group of modiﬁed Penn
Ab-2 þ Ac þ Abc is more similar to the meaning of
“complicated” ATAAD and the mixed group of
modiﬁed Penn Aa þ Ab-1 is closer to the meaning of
“uncomplicated” ATAAD. In short, we think the
validation of modiﬁed Penn classiﬁcation could
be easier to apply and more adequately point out
patients with higher risk of in-hospital mortality
after surgical repair.
Notably, a prevalence of 20% to 35% of patients
with ATAAD with shock (deﬁned as generalized
ischemia) was reported by a number of in-
vestigators. Nevertheless, Czerny et al. (1) did not
describe if they included this major confounder,
hemodynamic shock, and have not included it as
variable in the multivariate analysis. This was a
serious problem because hemodynamic shock is
strongly related to post-repair in-hospital mortality.
This ﬂaw calls into question the methodology of
investigation and its subsequent results. Thus, the
in-hospital mortality of patients with organ-speciﬁc
malperfusion might be overestimated or under-
estimated during statistical analysis, depending on
whether the hemodynamic shock is presented or
not in patients with organ-speciﬁc malperfusion.
Finally, since generalized malperfusion is the
strongest risk factor of post-repair in-hospital mor-
tality in patients with ATAAD by many investigators
(2,4) (see references 1, 3, and 5 in Chien et al. [5]),
we strongly recommend the investigators consider
the impact of generalized malperfusion as a major
confounder of pre-operative malperfusion on the
operative mortality risk for patients with ATAAD in
future analyses.Hsiu-Wen Li, MD
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Cardiol 2014;114:497–9.REPLY: Reconsidering the Impact of
Pre-Operative Malperfusion on Acute Type A
Dissection
The Modiﬁed Penn ClassiﬁcationWe thank Dr. Li and colleagues for their interest in
our paper (1). The genuine rationale for classiﬁcations
is to simplify complexity and, as the investigators
state, the Penn classiﬁcation is an excellent risk
stratiﬁcation tool to predict mortality on the ischemic
pattern at clinical presentation (2). However, any sub-
segmentation — despite that it might be justiﬁed and
may ﬁt — does not always help to make complex is-
sues easier to understand and does not always direct
the focus of a physician on a clinical path where the
diagnostic and therapeutic aim is reached more
rapidly. In general, a classiﬁcation has to be easy
to understand and self-explanatory, as we are well
aware that not all variations of a highly dynamic
process can be mapped. This is also the case when
